CHRT vs. CHG, BOE, GEC, SNR, AVON, VEL, HARL, AERO, RR, and BA
Should you be buying Cohort stock or one of its competitors? The main competitors of Cohort include Chemring Group (CHG), Boeing (BOE), General Electric (GEC), Senior (SNR), Avon Protection (AVON), Velocity Composites (VEL), Harland & Wolff Group (HARL), Strat Aero (AERO), Rolls-Royce Holdings plc (RR), and BAE Systems (BA). These companies are all part of the "aerospace & defense" industry.
Cohort vs. Its Competitors
Cohort (LON:CHRT) and Chemring Group (LON:CHG) are both small-cap industrials companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership, media sentiment and community ranking.
Chemring Group has a consensus price target of GBX 460, indicating a potential downside of 20.28%. Given Chemring Group's higher probable upside, analysts clearly believe Chemring Group is more favorable than Cohort.
Chemring Group received 225 more outperform votes than Cohort when rated by MarketBeat users. However, 77.63% of users gave Cohort an outperform vote while only 61.53% of users gave Chemring Group an outperform vote.
In the previous week, Chemring Group had 2 more articles in the media than Cohort. MarketBeat recorded 3 mentions for Chemring Group and 1 mentions for Cohort. Cohort's average media sentiment score of 1.16 beat Chemring Group's score of 0.48 indicating that Cohort is being referred to more favorably in the media.
Cohort pays an annual dividend of GBX 15 per share and has a dividend yield of 1.0%. Chemring Group pays an annual dividend of GBX 7 per share and has a dividend yield of 1.2%. Cohort pays out 39.6% of its earnings in the form of a dividend. Chemring Group pays out 857.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
36.2% of Cohort shares are owned by institutional investors. Comparatively, 114.2% of Chemring Group shares are owned by institutional investors. 39.2% of Cohort shares are owned by insiders. Comparatively, 1.7% of Chemring Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Cohort has higher earnings, but lower revenue than Chemring Group. Cohort is trading at a lower price-to-earnings ratio than Chemring Group, indicating that it is currently the more affordable of the two stocks.
Cohort has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500. Comparatively, Chemring Group has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500.
Cohort has a net margin of 7.56% compared to Chemring Group's net margin of 0.64%. Cohort's return on equity of 14.91% beat Chemring Group's return on equity.
Summary
Chemring Group beats Cohort on 11 of the 19 factors compared between the two stocks.
Get Cohort News Delivered to You Automatically
Sign up to receive the latest news and ratings for CHRT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CHRT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (LON:CHRT) was last updated on 6/13/2025 by MarketBeat.com Staff
